INDUSTRY SYMPOSIUM 3
13:15 - 15:15 Elicium 1
Individualization of HD therapy - the way to address clinical challenges
Chair: Claudio Ronco, Vicenza, Italy
Who benefits from HDF and why, based on recent clinical trials?
Paul Cockwell, Birmingham, UK
How to prevent intradialytic hypotension while reducing volume overload?
Rajiv Agarwal, Indianapolis, USA
Dialysis standard of care for high-bleeding-risk HD patients - what the HepZero study tells us
Maurice Laville, Lyon, France
Organised by GAMBRO